Efficacy of Bifidobacterium animalis subsp. lactis (BB-12), B. infantis and Lactobacillus acidophilus (La-5) probiotics to prevent gut dysbiosis in preterm infants of 28+0–32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study Protocol

INTRODUCTION: The healthy ‘eubiosis’ microbiome in infancy is regarded as the microbiome derived from term, vaginally delivered, antibiotic free, breastfed infants at 4–6 months. Dysbiosis is regarded as a deviation from a healthy state with reduced microbial diversity and deficient capacity to cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Marißen, Janina, Haiß, Annette, Meyer, Claudius, Van Rossum, Thea, Bünte, Lisa Marie, Frommhold, David, Gille, Christian, Goedicke-Fritz, Sybelle, Göpel, Wolfgang, Hudalla, Hannes, Pagel, Julia, Pirr, Sabine, Siller, Bastian, Viemann, Dorothee, Vens, Maren, König, Inke, Herting, Egbert, Zemlin, Michael, Gehring, Stephan, Bork, Peer, Henneke, Philipp, Härtel, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886923/
https://www.ncbi.nlm.nih.gov/pubmed/31753895
http://dx.doi.org/10.1136/bmjopen-2019-032617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886923/
https://www.ncbi.nlm.nih.gov/pubmed/31753895
http://dx.doi.org/10.1136/bmjopen-2019-032617

Ejemplares similares